EuroIntervention PCRonline - Connecting with the community

Keith D. Dawkins

42 articles

Insights into the Need for Permanent Pacemaker Following Implantation of the Repositionable LOTUS™ Valve for the Transcatheter Aortic Valve Replacement in 250 Patients: Results from the REPRISE II Trial With Extended Cohort

EuroIntervention 2017; just accepted article published in May 2017

Does geographical variability influence 5-year MACCE rates in the multicenter SYNTAX revascularization trial?

EuroIntervention 2017; just accepted article published in March 2017

Safety and efficacy of a bioabsorbable polymer-coated, everolimus-eluting coronary stent in patients with diabetes: the EVOLVE II diabetes substudy

EuroIntervention 2017;12:1987-1994 published online November 2016

Published in Volume 12 Number 16, March 2017

Fluorocopolymer-coated nitinol self-expanding paclitaxel-eluting stent: pharmacokinetics and vascular biology responses in a porcine iliofemoral model

EuroIntervention 2016;12:790-797

Published in Volume 12 Number 6, August 2016

Five-year outcomes of staged percutaneous coronary intervention in the SYNTAX study

EuroIntervention 2015;10:1402-1408

Published in Volume 10 Number 12, April 2015

One-year outcomes in 1,010 unselected patients treated with the PROMUS Element everolimus-eluting stent: the multicentre PROMUS Element European Post-Approval Surveillance Study

EuroIntervention 2015;10:1267-1271 published online ahead of print January 2015

Published in Volume 10 Number 11, March 2015

One-year outcomes in unselected patients treated with a thin-strut, platinum-chromium, paclitaxel-eluting stent: primary endpoint results from the TAXUS Element European post-approval surveillance study (TE-PROVE)

EuroIntervention 2015;10:1261-1266 published online ahead of print January 2015

Published in Volume 10 Number 11, March 2015

Transfemoral aortic valve replacement with the repositionable Lotus Valve System in high surgical risk patients: the REPRISE I study

EuroIntervention 2014;9:1264-1270 published online ahead of print October 2013

Published in Volume 9 Number 11, March 2014

The coronary artery bypass graft SYNTAX Score: final five-year outcomes from the SYNTAX-LE MANS left main angiographic substudy

EuroIntervention 2013;9:1009-1010 published online ahead of print April 2013

Published in Volume 9 Number 8, December 2013

Six-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent

EuroIntervention 2013;9:308-315 published online ahead of print May 2013

Published in Volume 9 Number 3, July 2013

The CABG SYNTAX Score - an angiographic tool to grade the complexity of coronary disease following coronary artery bypass graft surgery: from the SYNTAX Left Main Angiographic (SYNTAX-LE MANS) substudy

EuroIntervention 2013;8:1277-1285 published online ahead of print August 2012

Published in Volume 8 Number 11, March 2013

Boston Scientific Lotus valve

EuroIntervention 2012;8:Q70-Q74

Published in Volume 8 Supplement Q, September 2012

Vasomotor function and re-endothelialisation after implantation of biodegradable abluminal polymer coated paclitaxel-eluting stents in rabbit iliac arteries: a time-course study

EuroIntervention 2012;8:493-500

Published in Volume 8 Number 4, August 2012

Comparison of the SYNERGY with the PROMUS (XIENCE V) and bare metal and polymer-only Element control stents in porcine coronary arteries

EuroIntervention 2012;8:250-257

Published in Volume 8 Number 2, June 2012

Longitudinal stent deformation: quantitative coronary angiographic analysis from the PERSEUS and PLATINUM randomised controlled clinical trials

EuroIntervention 2012;8:187-195 publish online ahead of print March 2012

Published in Volume 8 Number 2, June 2012

Angiographic outcomes following stenting or coronary artery bypass surgery of the left main coronary artery: fifteen-month outcomes from the synergy between PCI with TAXUS express and cardiac surgery left main angiographic substudy (SYNTAX-LE MANS)

EuroIntervention 2011;7:670-679 publish online ahead of print July 2011

Published in Volume 7 Number 6, October 2011

Two-year clinical outcomes of paclitaxel-eluting stents for in-stent restenosis in patients from the ARRIVE programme

EuroIntervention 2011;7:314-322

Published in Volume 7 Number 3, July 2011

The platinum small vessel trial: evaluation of the novel thin-strut platinum-chromium promus element small vessel everolimus-eluting stent

Published in Volume 7 Supplement M, May 2011

PLATINUM QCA: a prospective, multicentre study assessing clinical, angiographic, and intravascular ultrasound outcomes with the novel platinum chromium thin-strut PROMUS Element everolimus-eluting stent in de novo coronary stenoses

EuroIntervention 2011;7:84-90

Published in Volume 7 Number 1, May 2011

A clinical risk score for the prediction of very late stent thrombosis in drug eluting stent patients

EuroIntervention 2011;6:949-954

Published in Volume 6 Number 8, March 2011

A prospective evaluation of the safety and efficacy of TAXUS Element paclitaxel-eluting coronary stent implantation for the treatment of de novo coronary artery lesions in small vessels: the PERSEUS Small Vessel trial

EuroIntervention 2011;6:920-927

Published in Volume 6 Number 8, March 2011

Vascular response to a third generation everolimus-eluting stent

EuroIntervention 2010;6:512-519

Published in Volume 6 Number 4, September 2010

First human use of the TAXUS Petal paclitaxel-eluting bifurcation stent

EuroIntervention 2010;6:46-53 - DOI10.4244/EIJV6I1A8

Published in Volume 6 Number 1, May 2010

Repeat left main revascularisation in patients with de novo left main disease treated with percutaneous coronary intervention using Taxus Express2 paclitaxel-eluting stent in the SYNTAX trial

Published in Volume 6 Supplement H, May 2010

Correlation of angiographic findings with clinical events following stenting or coronary artery bypass surgery of the left main coronary artery: 24-month outcomes from the synergy between percutaneous coronary intervention with Taxus express and cardiac surgery left main angiographic sub-study (SYNTAX-LE MANS)

Published in Volume 6 Supplement H, May 2010

Vascular response to a third generation Everolimus-eluting stent

Published in Volume 6 Supplement H, May 2010

Geographical differences in the TAXUS OLYMPIA Registry: 1-Year results in 22,000 patients

Published in Volume 5 Supplement E, May 2009

Clinical outcomes post implantation of the paclitaxel-eluting stent in saphenous vein graft lesions in routine clinical practice: insights from the ARRIVE 1 and ARRIVE 2 registries

Published in Volume 5 Supplement E, May 2009

Early and late graft occlusion and stent thrombosis: analysis from the SYNTAX Trial

Published in Volume 5 Supplement E, May 2009

Gender differences in stent thrombosis: insights from TAXUS WOMAN

Published in Volume 5 Supplement E, May 2009

Economic evaluation of drug-eluting stents vs. bypass surgery for patients with 3-vessel and left main coronary artery disease: 1-year results from the SYNTAX trial

Published in Volume 5 Supplement E, May 2009

Expanded use of the TAXUS Express Stent: two-year safety insights from the 7,500 patient ARRIVE Registry programme

EuroIntervention 2009;5:67-77 - DOI10.4244/EIJV5I1A11

Published in Volume 5 Number 1, May 2009

Assessment of the SYNTAX score in the Syntax study

EuroIntervention 2009;5:50-56 - DOI10.4244/EIJV5I1A09

Published in Volume 5 Number 1, May 2009

Counting the score: the SYNTAX Score and coronary risk

EuroIntervention 2009;5:33-35

Published in Volume 5 Number 1, May 2009

TAXUS VI final 5-year results: a multicentre, randomised trial comparing polymer-based moderate-release paclitaxel-eluting stent with a bare metal stent for treatment of long, complex coronary artery lesions

EuroInterv.2009;4 572-577

Published in Volume 4 Number 5, March 2009

Three-year follow-up of the ARTS-II# – Sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease

EuroInterv.2008;3:450-459

Published in Volume 3 Number 4, January 2008

Safety and efficacy of multiple, overlapping polymer-based paclitaxel-eluting stents

EuroInterv.2007;3:213-221

Published in Volume 3 Number 2, August 2007

The European cobalt STent with Antiproliferative for Restenosis trial (EuroSTAR): 12 month results

EuroInterv.2007;3:82-88

Published in Volume 3 Number 1, May 2007

Integrated analysis of medically treated diabetic patients in the TAXUS® program: benefits across stent platforms, paclitaxel release formulations, and diabetic treatments

EuroIntervention 2006;2:61-68 - DOI10.4244/EIJV2I1A11

Published in Volume 2 Number 1, May 2006

Physicians, the medical device industry and the data; a healthy relationship?

EuroInterv.2006;2:19-22

Published in Volume 2 Number 1, May 2006

The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease

EuroInterv.2005;2:219-227

Published in Volume 1 Number 2, August 2005

Arterial Revascularisation Therapies Study Part II - Sirolimus-eluting stents for the treatment of patients with multivessel de novo coronary artery lesions

EuroIntervention 2005;1:147-156 - DOI10.4244/EIJV1I2A25

Published in Volume 1 Number 2, August 2005